Mounjaro
-
healthGLP-1 Drugs May Cut Breast Cancer Risk by 30%, Study Finds
GLP-1 medications like Ozempic and Mounjaro may reduce breast cancer risk by up to 30%, independent of weight loss, new research shows.
-
healthGLP-1 Drugs Like Ozempic Show Broad Cancer Protection Promise
Multiple studies at ASCO 2024 show GLP-1 drugs reduce cancer risk and improve outcomes across tumor types, with potential benefits tied to inflammation reduction and weight loss.
-
healthFrance Becomes First EU Country to Reimburse Weight-Loss Drugs
France will start covering costs of Wegovy and Mounjaro from June 15, a historic move making it the first EU nation to offer permanent reimbursement for GLP-1 weight-loss medications.
-
healthHealth Canada Approves Second Generic Semaglutide from Apotex
Health Canada clears Apotex's generic semaglutide for type 2 diabetes, expanding access to alternatives for brand-name drugs like Ozempic.
-
healthNew Study Reveals Unreported Side Effects of Popular Weight-Loss Drugs
A University of Pennsylvania study analyzing Reddit posts uncovers potential new side effects of GLP-1 agonists like Ozempic and Mounjaro, beyond common gastrointestinal issues.
-
healthGenetics May Explain Varied Weight-Loss Drug Efficacy
New research suggests genetic factors influence how well individuals respond to popular weight-loss drugs like Ozempic and Mounjaro, offering insights into personalized treatment.
-
healthDrug Combination Shows 35% Greater Weight Loss in Post-Menopausal Women
Mayo Clinic study reveals tirzepatide combined with hormone therapy delivers superior weight loss results for women over 50.
-
healthStopping GLP-1 Drugs Erases Heart Benefits Fast, Study Warns
New research shows cardiovascular protection from Ozempic and similar drugs vanishes within months of stopping - with lasting damage.